CEN 294
Latest Information Update: 30 May 2001
At a glance
- Originator Tocor II
- Class Anti-inflammatories
- Mechanism of Action
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Inflammation
Most Recent Events
- 30 May 2001 Profile reviewed but no significant changes made
- 22 Apr 1997 No-Development-Reported for Inflammation in USA (Unknown route)
- 24 Oct 1995 New profile